Gerodias, Resalyn T.
HRN: 25-41-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/07/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/07/2024
07/13/2024
IV
2.25g
Q6H
Complicated UTI
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes